{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:14:06Z","timestamp":1787613246775,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20171081"],"award-info":[{"award-number":["BK20171081"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13046-019-1379-5","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T13:17:02Z","timestamp":1567775822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression"],"prefix":"10.1186","volume":"38","author":[{"given":"Jiayan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"issue":"5","key":"1379_CR1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"issue":"42","key":"1379_CR2","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.2174\/1381612820666140826154327","volume":"20","author":"D Melisi","year":"2014","unstructured":"Melisi D, Calvetti L, Frizziero M, Tortora G. Pancreatic cancer: systemic combination therapies for a heterogeneous disease. Curr Pharm Des. 2014;20(42):6660\u20139.","journal-title":"Curr Pharm Des"},{"issue":"35","key":"1379_CR3","doi-asserted-by":"publisher","first-page":"57379","DOI":"10.18632\/oncotarget.10545","volume":"7","author":"X Huang","year":"2016","unstructured":"Huang X, Zhi X, Gao Y, Ta N, Jiang H, Zheng J. LncRNAs in pancreatic cancer. Oncotarget. 2016;7(35):57379\u201390.","journal-title":"Oncotarget."},{"issue":"12","key":"1379_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/15384047.2017.1385682","volume":"18","author":"L Duguang","year":"2017","unstructured":"Duguang L, Jin H, Xiaowei Q, Peng X, Xiaodong W, Zhennan L, Jianjun Q, Jie Y. The involvement of lncRNAs in the development and progression of pancreatic cancer. Cancer Biol Ther. 2017;18(12):927\u201336.","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"1379_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrm3679","volume":"14","author":"S Geisler","year":"2013","unstructured":"Geisler S, Coller J. RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol. 2013;14(11):699\u2013712.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"1379_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155\u20139.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"1379_CR7","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.3390\/cancers11020234","volume":"11","author":"P Dong","year":"2019","unstructured":"Dong P, Xiong Y, Yue J, JB Hanley S, Kobayashi N, Todo Y, Watari H. Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges. Cancers (Basel). 2019;11(2):E234.","journal-title":"Cancers (Basel)"},{"issue":"7006","key":"1379_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350\u20135.","journal-title":"Nature."},{"key":"1379_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-319-23730-5_5","volume":"889","author":"MA Khan","year":"2015","unstructured":"Khan MA, Zubair H, Srivastava SK, Singh S, Singh AP. Insights into the role of microRNAs in pancreatic Cancer pathogenesis: potential for diagnosis, prognosis, and therapy. Adv Exp Med Biol. 2015;889:71\u201387.","journal-title":"Adv Exp Med Biol"},{"issue":"33","key":"1379_CR10","doi-asserted-by":"publisher","first-page":"23253","DOI":"10.18632\/oncotarget.25298","volume":"9","author":"P Dong","year":"2018","unstructured":"Dong P, Xiong Y, Yue J, Hanley SJB, Watari H. miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation. Oncotarget. 2018;9(33):23253\u201363.","journal-title":"Oncotarget."},{"issue":"3","key":"1379_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173912","volume":"12","author":"L Bai","year":"2017","unstructured":"Bai L, Wang H, Wang AH, Zhang LY, Bai J. MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer. PLoS One. 2017;12(3):e0173912.","journal-title":"PLoS One"},{"issue":"39","key":"1379_CR12","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1038\/s41388-018-0347-4","volume":"37","author":"P Dong","year":"2018","unstructured":"Dong P, Xiong Y, Yu J, Chen L, Tao T, Yi S, Hanley SJB, Yue J, Watari H, Sakuragi N. Control of PD-L1 expression by miR-140\/142\/340\/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer. Oncogene. 2018;37(39):5257\u201368.","journal-title":"Oncogene."},{"issue":"8","key":"1379_CR13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11(8):783\u20134.","journal-title":"Nat Methods"},{"issue":"1","key":"1379_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7150\/jca.16723","volume":"8","author":"W Huo","year":"2017","unstructured":"Huo W, Zhao G, Yin J, Ouyang X, Wang Y, Yang C, Wang B, Dong P, Wang Z, Watari H, Chaum E, Pfeffer LM, Yue J. Lentiviral CRISPR\/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells. J Cancer. 2017;8(1):57\u201364.","journal-title":"J Cancer"},{"issue":"4","key":"1379_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s13402-016-0275-7","volume":"39","author":"V Taucher","year":"2016","unstructured":"Taucher V, Mangge H, Haybaeck J. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application. Cell Oncol (Dordr). 2016;39(4):295\u2013318.","journal-title":"Cell Oncol (Dordr)"},{"issue":"3","key":"1379_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gy\u00f6rffy","year":"2010","unstructured":"Gy\u00f6rffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725\u201331.","journal-title":"Breast Cancer Res Treat"},{"issue":"Database issue","key":"1379_CR17","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1379_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fnins.2012.00196","volume":"6","author":"H Zhang","year":"2013","unstructured":"Zhang H, Shykind B, Sun T. Approaches to manipulating microRNAs in neurogenesis. Front Neurosci. 2013;6:196.","journal-title":"Front Neurosci"},{"key":"1379_CR19","doi-asserted-by":"publisher","first-page":"22312","DOI":"10.1038\/srep22312","volume":"6","author":"H Chang","year":"2016","unstructured":"Chang H, Yi B, Ma R, Zhang X, Zhao H, Xi Y. CRISPR\/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo. Sci Rep. 2016;6:22312.","journal-title":"Sci Rep"},{"issue":"4","key":"1379_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/biomedicines6040105","volume":"6","author":"Marta Martinez-Lage","year":"2018","unstructured":"Martinez-Lage M, Puig-Serra P, Menendez P, Torres-Ruiz R, Rodriguez-Perales S. CRISPR\/Cas9 for Cancer Therapy: Hopes and Challenges. Biomedicines. 2018;6(4).","journal-title":"Biomedicines"},{"issue":"6","key":"1379_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.tibs.2016.04.003","volume":"41","author":"R Fiume","year":"2016","unstructured":"Fiume R, Jones DR, Divecha N. PIP4K2B: coupling GTP sensing to PtdIns5P levels to regulate tumorigenesis. Trends Biochem Sci. 2016;41(6):473\u20135.","journal-title":"Trends Biochem Sci"},{"issue":"23","key":"1379_CR22","doi-asserted-by":"publisher","first-page":"6913","DOI":"10.1158\/0008-5472.CAN-13-0424","volume":"73","author":"WJ Keune","year":"2013","unstructured":"Keune WJ, Sims AH, Jones DR, Bultsma Y, Lynch JT, Jirstr\u00f6m K, Landberg G, Divecha N. Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: a role for PIP4K2B in the regulation of E-cadherin expression. Cancer Res. 2013;73(23):6913\u201325.","journal-title":"Cancer Res"},{"key":"1379_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.omtn.2018.09.026","volume":"13","author":"B Liu","year":"2018","unstructured":"Liu B, Wu S, Ma J, Yan S, Xiao Z, Wan L, Zhang F, Shang M, Mao A. lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221\/SOCS3 in Pancreatic Cancer. Mol Ther Nucleic Acids. 2018;13:472\u201382.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"1379_CR24","first-page":"1591","volume":"39","author":"Z Sun","year":"2018","unstructured":"Sun Z, Zhang B, Cui T. Long non-coding RNA XIST exerts oncogenic functions in pancreatic cancer via miR-34a-5p. Oncol Rep. 2018;39(4):1591\u2013600.","journal-title":"Oncol Rep"},{"issue":"1","key":"1379_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-017-0738-0","volume":"16","author":"H Li","year":"2017","unstructured":"Li H, Wang X, Wen C, Huo Z, Wang W, Zhan Q, Cheng D, Chen H, Deng X, Peng C, Shen B. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Mol Cancer. 2017;16(1):169.","journal-title":"Mol Cancer"},{"issue":"1","key":"1379_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/jcmm.13351","volume":"22","author":"X Zhao","year":"2018","unstructured":"Zhao X, Liu Y, Li Z, Zheng S, Wang Z, Li W, Bi Z, Li L, Jiang Y, Luo Y, Lin Q, Fu Z, Rufu C. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. J Cell Mol Med. 2018;22(1):655\u201367.","journal-title":"J Cell Mol Med"}],"updated-by":[{"DOI":"10.1186\/s13046-020-01573-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000}}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1379-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1379-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1379-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T23:24:13Z","timestamp":1599175453000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1379-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1379-5","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13046-020-01573-3","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"2 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of this manuscript [1], there are errors in Fig.\ufffd\ufffd3. The authors declare that the identified errors do not change the results or conclusions of this paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Ethics Committee of Renji Hospital, School of Medicine, Shanghai Jiaotong University, and informed consent was obtained from all patients. All operations as described above were approved the Institutional Animal Care and Use Committee of Renji Hospital, School of Medicine, Shanghai Jiaotong University. All animal treatments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"390"}}